UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding

Cancer research (Chicago, Ill.), 2009-03, Vol.69 (5), p.1958-1965

2009

Volltextzugriff (PDF)

Reciprocal Regulation of c-Src and STAT3 in Non-Small Cell Lung Cancer

Clinical cancer research, 2009-11, Vol.15 (22), p.6852-6861

2009

Volltextzugriff (PDF)

Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion

Molecular cancer therapeutics, 2012-09, Vol.11 (9), p.2021-2032

2012

Volltextzugriff (PDF)

EphA2 in the early pathogenesis and progression of non-small cell lung cancer

Cancer prevention research (Philadelphia, Pa.), 2009-12, Vol.2 (12), p.1039-1049

2009

Volltextzugriff (PDF)

Antiparasitic chemotherapy: tinkering with the purine salvage pathway

Advances in experimental medicine and biology, 2008, Vol.625, p.116

2008

Volltextzugriff (PDF)

Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib

Science translational medicine, 2012-05, Vol.4 (136), p.136ra70

2012

Volltextzugriff (PDF)

Regulation of Src Family Kinases in Human Cancers

Journal of Signal Transduction, 2011-01, Vol.2011 (2011), p.316-329

2011

Volltextzugriff (PDF)

Distinct Interactions Between c-Src and c-Met in Mediating Resistance to c-Src Inhibition in Head and Neck Cancer

Clinical cancer research, 2011-02, Vol.17 (3), p.514-524

2011

Volltextzugriff (PDF)

STAT5A-Mediated SOCS2 Expression Regulates Jak2 and STAT3 Activity Following c-Src Inhibition in Head and Neck Squamous Carcinoma

Clinical cancer research, 2012-01, Vol.18 (1), p.127-139

2012

Volltextzugriff (PDF)

Abstract IA10: Kinase-impaired BRAF mutations as predictors of resistance and sensitivity

Clinical cancer research, 2015-02, Vol.21 (4_Supplement), p.IA10-IA10

2015

Volltextzugriff (PDF)

Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers

Journal of translational medicine, 2013-08, Vol.11 (1), p.198-198, Article 198

2013

Volltextzugriff (PDF)

Abstract 3707: The multitargeted kinase inhibitor dasatinib induces DNA damage, Hippo pathway engagement and senescence in lung cancer cell lines that possess kinase-inactivating BRAF mutations

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3707-3707

2014

Volltextzugriff (PDF)

Dasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutations

Oncotarget, 2016-01, Vol.7 (1), p.565-579

2016

Volltextzugriff (PDF)

Abstract 4005: JAK/STAT activation following Src inhibition is mediated by the loss of SOCS2 expression

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.4005-4005

2010

Volltextzugriff (PDF)

Abstract 4095: Paradoxical activation of the RAF-MEK-ERK pathway in response to nilotinib induces synthetic lethality with MEK inhibition in head and neck cancer cells

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.4095-4095

2013

Volltextzugriff (PDF)

Drug-induced RAF dimerization is independent of RAS mutation status and does not lead to universal MEK dependence for cell survival in head and neck cancers

Anti-cancer drugs, 2015-09, Vol.26 (8), p.835-842

2015

Volltextzugriff (PDF)

A Single-domain Cyclophilin from Leishmania donovaniReactivates Soluble Aggregates of Adenosine Kinase by Isomerase-independent Chaperone Function

The Journal of biological chemistry, 2002-12, Vol.277 (49), p.47451-47460

2002

Volltextzugriff (PDF)

Abstract 333: Molecular and histologic characterization a patient-derived heterotransplant mouse model of head and neck squamous carcinoma

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.333-333

2013

Volltextzugriff (PDF)

Abstract 2361: Establishing a patient-derived heterotransplant mouse model of head and neck squamous carcinoma (HNSCC)

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2361-2361

2012

Volltextzugriff (PDF)

Abstract 3667: Inactivating BRAF mutations confer dasatinib sensitivity in lung cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3667-3667

2012

Volltextzugriff (PDF)

Abstract 1046: Differential interactions between c-Src and c-Met mediate resistance to c-Src inhibitors

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1046-1046

2011

Volltextzugriff (PDF)

Abstract 5578: SOCS2 (suppressor of cytokine signaling protein 2) is a prognostic indicator of progression-free survival in head and neck squamous cell carcinoma (HNSCC) patients

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.5578-5578

2013

Volltextzugriff (PDF)

Erratum to: Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and Histologic characteristics of human cancers

Journal of translational medicine, 2014-03, Vol.12

2014

Volltextzugriff (PDF)

Sustained Src Inhibition Results in STAT3 Activation and Cancer Cell Survival via Altered JAK-STAT3 Binding

Cancer research (Chicago, Ill.), 2009-02, Vol.69 (5), p.1958-1965

2009

Volltextzugriff (PDF)

Sustained Src Inhibition Results in Signal Transducer and Activator of Transcription 3 (STAT3) Activation and Cancer Cell Survival via Altered Janus-Activated Kinase―TAT3 Binding

Cancer research (Chicago, Ill.), 2009, Vol.69 (5), p.1958-1965

2009

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(18)
Animals
(15)
Technology
(14)
Engineering
(11)
Engineering, Electrical & Electronic
(11)
Humans
(11)
Physical Sciences
(9)
Micromechanical Devices
(8)
Oncology
(8)
Biochemistry & Molecular Biology
(7)
Cell Line, Tumor
(7)
Nanoscience & Nanotechnology
(7)
Science & Technology - Other Topics
(7)
Adenosine Kinase - Metabolism
(6)
Binding Sites
(6)
Electrostatics
(6)
Materials Science
(6)
Materials Science, Multidisciplinary
(6)
Physics
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding

Reciprocal Regulation of c-Src and STAT3 in Non-Small Cell Lung Cancer

Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion

EphA2 in the early pathogenesis and progression of non-small cell lung cancer

Antiparasitic chemotherapy: tinkering with the purine salvage pathway

Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib

Regulation of Src Family Kinases in Human Cancers

Distinct Interactions Between c-Src and c-Met in Mediating Resistance to c-Src Inhibition in Head and Neck Cancer

STAT5A-Mediated SOCS2 Expression Regulates Jak2 and STAT3 Activity Following c-Src Inhibition in Head and Neck Squamous Carcinoma

Abstract IA10: Kinase-impaired BRAF mutations as predictors of resistance and sensitivity

Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers

Abstract 3707: The multitargeted kinase inhibitor dasatinib induces DNA damage, Hippo pathway engagement and senescence in lung cancer cell lines that possess kinase-inactivating BRAF mutations

Dasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutations

Abstract 4005: JAK/STAT activation following Src inhibition is mediated by the loss of SOCS2 expression

Abstract 4095: Paradoxical activation of the RAF-MEK-ERK pathway in response to nilotinib induces synthetic lethality with MEK inhibition in head and neck cancer cells

Drug-induced RAF dimerization is independent of RAS mutation status and does not lead to universal MEK dependence for cell survival in head and neck cancers

A Single-domain Cyclophilin from Leishmania donovaniReactivates Soluble Aggregates of Adenosine Kinase by Isomerase-independent Chaperone Function

Abstract 333: Molecular and histologic characterization a patient-derived heterotransplant mouse model of head and neck squamous carcinoma

Abstract 2361: Establishing a patient-derived heterotransplant mouse model of head and neck squamous carcinoma (HNSCC)

Abstract 3667: Inactivating BRAF mutations confer dasatinib sensitivity in lung cancer

Abstract 1046: Differential interactions between c-Src and c-Met mediate resistance to c-Src inhibitors

Abstract 5578: SOCS2 (suppressor of cytokine signaling protein 2) is a prognostic indicator of progression-free survival in head and neck squamous cell carcinoma (HNSCC) patients

Erratum to: Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and Histologic characteristics of human cancers

Sustained Src Inhibition Results in STAT3 Activation and Cancer Cell Survival via Altered JAK-STAT3 Binding

Sustained Src Inhibition Results in Signal Transducer and Activator of Transcription 3 (STAT3) Activation and Cancer Cell Survival via Altered Janus-Activated Kinase―TAT3 Binding

Suchergebnisse filtern